RNAZ transcodetherapeutics.com: Accounting Value per Share

Graphic logo of TransCode Therapeutics, Inc. (RNAZ)

TransCode Therapeutics is developing the innovative TTX system for the targeted destruction of metastases. The book value per share illustrates capital dynamics, where -27.51 represents the current level of the metric. The operating model is based on external molecule synthesis and outsourced research. The absence of commercial sales and the early stages of development make the stock price dependent on new investments.

TransCode Therapeutics (RNAZ) Equity per Share: for the period 07/04/2022 - 10/27/2026

RNAZ (TransCode Therapeutics Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price TransCode|RNAZ - Analyst Consensus Forecast
- market capitalization data:
Market Valuation TransCode Therapeutics, Inc.|RNAZ - Full Business Value
- book capitalization data:
Book Value per Share TransCode Therapeutics|RNAZ - Accounting Capitalization|Market Value to Book Value Ratio transcodetherapeutics.com|RNAZ - Total Business Assets
- debt and liquidity data:
Total Debt to Capital TransCode Therapeutics|RNAZ - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio TransCode|RNAZ - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio TransCode Therapeutics, Inc.
Fundamental company valuation:RNAZ transcodetherapeutics.com
Manufactured products of TransCode Therapeutics

Book value reflects the company's net assets minus all liabilities, determining the intrinsic value per share to assess investor overpayment. Analyzing the reported book value per share reveals how the asset capitalization of TransCode Therapeutics (RNAZ) supports the RNA drug R&D pipeline amidst a prolonged academic cycle of preclinical research without operating profit.

Competitors of TransCode Therapeutics (RNAZ)

Tempus AI, Inc. - Book Value per Share|Qiagen Corp (QGEN) - Book Value per Share|Accounting Value per Share Ionis Pharmaceuticals (IONS)|repligen.com (RGEN) - Share Book Value|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|SRPT - Book Value per Share|Accounting Value per Share Twist Bioscience, Inc. TWST|TXG: Book Price of a Share|Net Assets per Single Share Intellia NTLA|Stoke Corp (STOK) - Accounting Value of a Share|BLFS (BioLife Solutions, Inc.) - Book Value per Share|Book Value per Share WVE|Net Assets per Single Share Maze Therapeutics MAZE|Equity per Share SION (Sionna Therapeutics, Inc.)|Net Assets per Single Share PRME|Net Assets per Share Taysha Corp TSHA|QURE: Book Value per Share|MGTX: Accounting Value per Share|Net Assets per Single Share RGNX|Solid Biosciences Inc (SLDB) - Net Asset Value per Share|Book Value per Share Ocugen Corp (OCGN)|Equity per Share PacBio Corp|Benitec Biopharma Inc. - Book Value per Share|Net Asset Value per Share designtx.com DSGN|Accounting Value per Share Rocket Pharmaceuticals, Inc.|FDMT - Accounting Value of a Share|Accounting Value per Share Lexeo LXEO|KRRO - Book Price of a Share|Book Value per Share Editas Medicine, Inc. EDIT|silence-therapeutics.com (SLN) - Accounting Value of a Share|Book Value per Share PRQR (ProQR)|Net Asset Value per Share CDXS|Sangamo (SGMO) - Net Assets per Single Share|Accounting Value of a Share nautilus.bio (NAUT)|Book Value per Share MGX (Metagenomi, Inc.)|Precision BioSciences Inc. - Book Value per Share|Net Assets per Single Share Generation Bio Corp|BOLD - Share Book Value|Book Value per Share XCUR|Net Asset Value per Share Imunon|PHIO (Phio Pharmaceuticals Corp) - Accounting Value per Share|Book Value per Share Mustang Bio Corp (MBIO)|Accounting Value per Share Bionano Genomics, Inc.|Book Price of a Share Applied DNA Sciences Inc (APDN)|Book Value per Share BLUE|Net Assets per Share ImmunoPrecise Antibodies Ltd IPA|OMGA: Book Value per Share|OMIC: Accounting Value per Share|Regulus Therapeutics Inc. - Net Assets per Single Share|SYRS (Syros Pharmaceuticals Inc.) - Net Assets per Share|TBIO - Net Assets per Single Share|Accounting Value of a Share TCON|Net Assets per Single Share Unity Biotechnology UBX